Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodayPrecious Metals
Gold Price TodayNew
Silver Price TodayNew
Platinum Price TodayNewSmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Shalby
Small Cap•2,853 Employees•IPO 2017
Current Price
₹161.26
-2.49 (-1.52%)Updated
Today's Range
157.5
₹161.26
166.59
52 Week Range
52W Low₹125.82
52W High₹274.70
₹161.26
Downside28.17%
Upside70.35%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹1,725.46 Cr
Market Cap
Total market value of companyP/E Ratio
214.16
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
2.83
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹0.75
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
-0.26%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
6.12%
ROCE
Return on Capital Employed. >15% is goodNet Margin
0.72%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
-25.69%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
17.43%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
6.29%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
-43.00%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.48
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹92.31
Book Value
Net asset value per shareDividend Yield
-%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
74.30%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
5 points- •Strong promoter holding (74.3%) indicates firm confidence in long-term prospects.
- •Sustained revenue growth with 5-year CAGR of 17.43% is positive.
Weaknesses
5 points- •Significant quarterly profit decline of -43.00% signals operational challenges.
- •Reported net loss of -0.52 Cr and negative TTM EPS -0.28.
Opportunities
5 points- •Robust hospital industry growth offers significant avenues for market share expansion.
- •Foreign Institutional Investors' holding increased from 3.92% to 4.63%.
Threats
4 points- •Intense competition from larger, more profitable peers like Apollo Hospitals.
- •Stock price volatility with wide 52-week range (177-275) is a concern.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹184.25 | +₹22.99 | +14.25% |
| R3 | ₹175.16 | +₹13.90 | +8.62% |
| R2 | ₹170.87 | +₹9.61 | +5.96% |
| R1 | ₹166.07 | +₹4.81 | +2.98% |
| PIVOT | ₹161.78 | 0.52 | 0.32% |
| CURRENT | ₹161.26 | - | - |
| S1 | ₹138.80 | -₹22.46 | -13.93% |
| S2 | ₹147.89 | -₹13.37 | -8.29% |
| S3 | ₹152.69 | -₹8.57 | -5.31% |
| S4 | ₹156.98 | -₹4.28 | -2.66% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume+3.5% vs avg
1.14L
(29 Apr 2026)Delivery %-7.5% vs avg
40.3%
(29 Apr 2026)Avg Volume (20D)20-day average
1.10L
(30 Mar - 29 Apr)Avg Delivery %Trend ↓
47.7%
(30 Mar - 29 Apr)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Apollo Hospitals Enterprise Ltd
1.09L ₹ Cr
Best Profit Growth
Apollo Hospitals Enterprise Ltd
41.80 %
Highest Dividend Yield
Indraprastha Medical Corporation Ltd
1.13 %
Peer Comparison
| Company Name |
|---|
 Apollo Hospitals Enterprise Ltd |
 Artemis Medicare Services Ltd |
 GPT Healthcare Ltd |
 Indraprastha Medical Corporation Ltd |
 |
 Lotus Eye Hospital & Institute Ltd |
 Max India Ltd |
 Yatharth Hospital & Trauma Care Services Ltd |
About
Shalby Ltd
Shalby Limited is a multinational healthcare company with a significant presence in India and expanding operations internationally, including the United States, Japan, Indonesia, Oman, the UAE, Bangladesh, and Nepal. Its core business revolves around the operation of multi-specialty hospitals, providing a wide range of medical services.
The company's Healthcare Services segment encompasses a vast spectrum of medical specializations. This includes surgical procedures such as arthroscopy, arthroplasty, and various types of transplants (liver, organ), along with extensive diagnostic and therapeutic services. The range of specialties is broad, covering cardiology, oncology, neurology, gastroenterology, ophthalmology, orthopedics, and many more. They also offer comprehensive care in areas like emergency medicine, intensive care, and pediatrics. Beyond inpatient care, Shalby provides outpatient services and home healthcare solutions such as ICU at home, nursing care, and physiotherapy.
In addition to its healthcare services, Shalby operates a Manufacturing segment focused on the design, development, and manufacture of orthopedic implants. This vertical integration allows Shalby to control aspects of its supply chain and potentially offer cost-effective solutions within its hospital system.
Shalby further distinguishes itself through its educational initiatives, providing training programs for paramedical students and healthcare professionals. This investment in education and training contributes to the development of skilled healthcare personnel and supports the company's overall growth strategy. In essence, Shalby Limited is a diversified healthcare organization that integrates hospital operations, medical device manufacturing, and educational programs to provide comprehensive healthcare services across various locations globally.
COMPANY FACTS - SHALBY
Registered Address
Opp. Karnavati Club, S G Road
Ahmedabad
GUJARAT
IN
Company Details
Group: Health Care Equipment & Services
Sector: Health Care
Industry: Health Care Providers & Services
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 2,853
IPO Date: 15/12/2017
MANAGEMENT - SHALBY
Dr. Vikram Shah
Chairman of the Board, Managing Director
Mr. Amit Pathak
Chief Financial Officer
Mr. Deepak Ananthakrishnan
Global Chief Business Officer
Mr. Shanay Shah
Designated Director of International Business
Mr. Tushar Shah
Company Secretary, Associate Vice President
Dr. Ashok Bhatia
Non-Executive Independent Director
Shri. Shyamal Joshi
Non-Executive Independent Director
Mr. Vijay Kedia
Non-Executive Independent Director
Mr. Tej Malhotra
Non-Executive Independent Director
Dr. Umesh Menon
Non-Executive Independent Director
Mrs. Sujana Shah
Non-Executive Independent Director
Mr. Puneet Maheshwari
Investor Relations
Investor Questions Answered
Shalby Ltd (SHALBY) Stock FAQs
Get answers to the most common questions about Shalby Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Shalby Ltd (SHALBY) is ₹161.26. Today, the stock has declined by ₹2.49 (1.52%), trading in a range of ₹157.5 to ₹166.59. The stock opened at ₹163.75 with a trading volume of 1,13,724 shares.
Shalby Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹1,725.46 crores, P/E ratio of 214.16, ROE of -0.26%, and ROCE of 6.12%. The dividend yield stands at 0.00%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Shalby Ltd (SHALBY) is ₹274.7, while the 52-week low is ₹125.82. Currently trading at ₹161.26, the stock is 23.8% away from its 52-week low and 41.3% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Shalby Ltd stock at ₹161.26 depends on multiple factors. The stock is currently trading with a P/E ratio of 214.16 and P/B ratio of N/A. Today's performance shows a loss of 1.52%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Shalby Ltd offers a dividend yield of 0.00%, which means for every ₹100 invested at the current price of ₹161.26, you can expect to receive approximately ₹0.00 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Shalby Ltd's key financial metrics include: P/E Ratio: 214.16, P/B Ratio: N/A, ROE: -0.26%, ROCE: 6.12%, Dividend Yield: 0.00%, EPS: ₹0.75, Book Value: ₹92.31, Debt-to-Equity: 0.48, and Current Ratio: N/A. The company's market cap stands at ₹1,725.46 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Shalby Ltd stock opened at ₹163.75 and is currently trading at ₹161.26, showing a decline of ₹2.49 (1.52%). The intraday high is ₹166.59 and low is ₹157.5. The trading volume stands at 1,13,724 shares, indicating moderate market participation today.
Shalby Ltd has a Price-to-Earnings (P/E) ratio of 214.16, which means investors are willing to pay ₹214.16 for every ₹1 of earnings. With an EPS of ₹0.75, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
Shalby Ltd has a market capitalization of ₹1,725.46 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹161.26) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Shalby Ltd has a book value of ₹92.31 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹161.26, which is 74.7% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Shalby Ltd has a Return on Equity (ROE) of -0.26% and Return on Capital Employed (ROCE) of 6.12%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These returns may need improvement for better profitability. Higher percentages generally indicate better financial performance.
Shalby Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Shalby Ltd has a debt-to-equity ratio of 0.48, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Shalby Ltd has an Earnings Per Share (EPS) of ₹0.75, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹161.26 and P/E ratio of 214.16, investors are paying 214.16 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Shalby Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Shalby Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Shalby Ltd stock, consider: 1) Fundamental Analysis - Review P/E (214.16), ROE (-0.26%), debt-to-equity (0.48), and growth rates. 2) Technical Analysis - Check 52-week range (₹125.82 - ₹274.70), moving averages, and chart patterns. 3) Valuation - Compare current price (₹161.26) with book value (₹92.31) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Shalby Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹161.26 is 1513x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Shalby Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹125.82 - ₹274.70). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.48 indicates leverage. 4) Liquidity Risk - Based on trading volume of 1,13,724 shares. 5) Valuation Risk - P/E of 214.16 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Shalby Ltd operates in the industry with key metrics: P/E ratio of 214.16, ROE of -0.26%, market cap of ₹1,725.46 crores, and dividend yield of 0.00%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.48), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Shalby Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹161.26, with a 52-week range of ₹125.82 to ₹274.70. Based on fundamentals like P/E (214.16), ROE (-0.26%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Shalby Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹161.26. 2) Fundamental Deterioration - Declining ROE (currently -0.26%), increasing debt (D/E: 0.48), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Shalby Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 0.00%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu